AGING MALE, HORMONAL AND GENETIC ALTERATIONS
Authors:
MUDr. Rastislav Beharka
Authors‘ workplace:
Jihlavská 20, 625 00 Brno
e-mail: rbeharka@fnbrno. cz
; Urologická klinika LF MU a FN Brno
Published in:
Urol List 2007; 5(3): 40-45
Overview
Aging is a process which is manifested at a multiorgan level. The function of the central nervous system (primarily the brain), of the immune, endocrine, cardiovascular and locomotion systems deteriorate with age. The changes which are manifested as aging result from changes originating in the genetic material and changes at the level of hormonal regulation.
Key words:
aging male, endocrine aspects of aging, genetic aspects of aging, telomerstelomerase
Sources
1. Stárka L et al. Aktuální endokrinologie. Praha: Maxdorf 1999: 12-14, 162-168.
2. Baulieu EE. Dehydroepiandrosterone (DHEA): a fountain of youth? J Clin Endocr Metab 1996; 81: 3147-3151.
3. Ebeling P, Koivisto VA. Physiological importance of dehydroepiandrosterone. Lancet 1994; 343: 1479-1481.
4. Weksler M. Hormonereplacement for men. BMJ 1996; 312: 859-860.
5. Šonka J. Dehydroepiandrosterone, metabolic effects. Acta Univ Carol Monografia 1976; 71: 1-115.
6. Robel P, Baulieu EE. Neurosteroids: biosynthesis and function. In: Dekloet RR, Sutanto W (eds). Neurobiology of steroids. San diego: Academic Press 1994: 36-50.
7. Haus E, Nicolau G, Dumitriu et al. Stimulation of the secretion of dehydroepiandrosterone by melatonin in mouse adrenals in vitro. Life Sci 1996; 58: 263-267.
8. Kalimi M, Shafagoj Y, Loria et al. Anti-glucocorticoid effects of dehydroepiandrosterone. Mol Cell Biochem 1994; 131: 99-104.
9. Morales AJ, Nolan JJ, Nelson JC, Yen SSC. Effect of replacement dose of dehydroepiandrosterone in men and women of advancing age. J Clin Endocr Metab 1994; 78: 1360-1367.
10. Lamberts SWJ, van den Beld AW, van der Lely AJ. The endocrinology of aging. Science 1997; 278: 419-424.
11. Campisi J. The biology of replicative senescence. Eur J Cancer 1997; 33: 703-709.
12. Oshimura M, Barrett JC. Multiple pathways to cellular senescence: role of telomerase repressors. Eur J Cancer 1997; 33: 710-715.
13. Parkinson EK, Newbold RF, Keith WN. The genetic basis of human keratinocyte immortalisation in squamous cell carcinoma development: the role of telomerase reactivation. Eur J Cancer 1997; 33: 727-734.
14. Wang E. Senescent human fibroblasts resist programmed cell death and failure to suppress bcl2 is involved. Cancer Res 1995; 55: 2284-2292.
15. Shay JW, Wright W, Srivastava S et al. Researchers debate clinical role of telomerase. J Natl Cancer Inst 1996; 88: 1021-1023.
16. Harrington L, McPhail T, Mar V et al. A mammalian telomerase-associated protein. Science 1997; 275: 973-975.
17. Smith S, DeLange T. TRF1, a mammalian telomeric protein. TIG 1997; 13: 21-26.
18. Conrad MN, Dominquez AM, Dresser ME. Ndj1p, a meiotic telomere protein required for normal chromosome synapsis and segregation in yeast. Science 1997; 276: 1252-1256.
19. Rhyu M. Telomeres, telomerase, and immortality. J Natl Cancer Inst 1995; 87: 884-894.
20. Holt SE, Wright WE, Shay JW. Multiple pathways for the regulation of telomerase activity. Eur J Cancer 1997; 33: 761-766.
21. Rhyu M. Telomeres, telomerase, and immortality. J Natl Cancer Inst 1995; 87: 884-894.
22. Holt SE, Wright WE, Shay JW. Multiple pathways for the regulation of telomerase activity. Eur J Cancer 1997; 33: 761-766.
Labels
Paediatric urologist UrologyArticle was published in
Urological Journal
2007 Issue 3
Most read in this issue
- ERECTILE DYSFUNCTION FOLLOWING RADICAL PROSTATECTOMY
- Dihydrotestosterone and inhibitors of steroid 5α-REDUCTASE
- MALE CONTRACEPTION
- Is testosterone supplementation a potential risk for the prostate gland of an ageing male?